NEW STRATEGIES IN DRUG DEVELOPMENT AND CLINICAL-EVALUATION - THE POPULATION APPROACH - COMMENTARY ON AN ACTION FOR COOPERATIVE RESEARCH

被引:12
作者
BALANT, LP
ROWLAND, M
AARONS, L
MENTRE, F
MORSELLI, PL
STEIMER, JL
VOZEH, S
机构
[1] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
[2] UNIV GENEVA,DEPT PSYCHIAT,CLIN RES UNIT,CH-1211 GENEVA 4,SWITZERLAND
[3] INSERM,F-75005 PARIS,FRANCE
[4] SYNTHELABO LERS,F-75621 PARIS 13,FRANCE
[5] SANDOZ PHARMA AG,DRUG SAFETY ASSESSMENT,BASEL,SWITZERLAND
[6] OFF INTERCANTONAL CONTROLE MED,BERN,SWITZERLAND
关键词
DRUG DEVELOPMENT; CLINICAL EVALUATION; NEW STRATEGIES;
D O I
10.1007/BF00315486
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:93 / 94
页数:2
相关论文
共 2 条
[1]  
ROWLAND M, 1985, VARIABILITY DRUG THE
[2]  
ROWLAND M, 1992, NEW STRATEGIES DRUG